Pharmacists as immunizers to Improve coverage and provider/recipient satisfaction: A prospective, Controlled Community Embedded Study with vaccineS with low coverage rates (the Improve ACCESS Study): Study summary and anticipated significance

Jennifer E. Isenor; Melissa S. Kervin; Donna M. Halperin; Joanne Langley; Julie A. Bettinger; Karina A. Top; Fawziah Lalji; Kathryn Slayter; Janusz Kaczorowski; Susan K. Bowles; Nancy M. Waite; Scott A. Halperin; Beth Taylor; Shelly McNeil

doi:10.1177/1715163519900221

Pharmacists as immunizers to Improve coverage and provider/recipient satisfaction: A prospective, Controlled Community Embedded Study with vaccineS with low coverage rates (the Improve ACCESS Study): Study summary and anticipated significance

Jennifer E. Isenor, Melissa S. Kervin, Donna M. Halperin, Joanne Langley, Julie A. Bettinger, Karina A. Top, Fawziah Lalji, Kathryn Slayter, Janusz Kaczorowski, Susan K. Bowles, Nancy M. Waite, Scott A. Halperin, Beth Taylor, Shelly McNeil

Medicine

Research output: Contribution to journal › Article › peer-review

5 Citations (Scopus)

Original language	English
Pages (from-to)	88-94
Number of pages	7
Journal	Canadian Pharmacists Journal
Volume	153
Issue number	2
DOIs	https://doi.org/10.1177/1715163519900221
Publication status	Published - Mar 1 2020

Bibliographical note

Funding Information:
The Improve ACCESS Team reports grant funding from GlaxoSmithKline Biologicals SA and Sanofi Pasteur Limited.

Funding Information:
This study was funded by the Canadian Institutes of Health Research (CIHR) through the Canadian Immunization Research Network (CIRN) and through Collaborative Research Agreements with GlaxoSmithKline Biologicals SA and Sanofi Pasteur Limited. The authors acknowledge the generous in-kind support provided by the participating community pharmacies for waiving the injection fee for the Tdap vaccine and Neighbourhood Pharmacy Association of Canada. The authors thank the dedicated pharmacists and pharmacy staff whose tremendous efforts make this study possible. Finally, we thank the following additional members of The Improve ACCESS Team: Beth Taylor and Shelly McNeil. This work was supported by the Canadian Institutes of Health Research (CIHR) through the Canadian Immunization Research Network (CIRN), GlaxoSmithKline Biologicals SA and Sanofi Pasteur Limited. All supporters were provided the opportunity to review a preliminary version of this manuscript for factual accuracy, but the authors are solely responsible for final content and interpretation. The authors received no financial support or other form of compensation related to the development of the manuscript.

Funding Information:
This work was supported by the Canadian Institutes of Health Research (CIHR) through the Canadian Immunization Research Network (CIRN), GlaxoSmithKline Biologicals SA and Sanofi Pasteur Limited. All supporters were provided the opportunity to review a preliminary version of this manuscript for factual accuracy, but the authors are solely responsible for final content and interpretation. The authors received no financial support or other form of compensation related to the development of the manuscript.

ASJC Scopus Subject Areas

Pharmacy
Pharmaceutical Science

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1177/1715163519900221

Cite this

Isenor, J. E., Kervin, M. S., Halperin, D. M., Langley, J., Bettinger, J. A., Top, K. A., Lalji, F., Slayter, K., Kaczorowski, J., Bowles, S. K., Waite, N. M., Halperin, S. A., Taylor, B., & McNeil, S. (2020). Pharmacists as immunizers to Improve coverage and provider/recipient satisfaction: A prospective, Controlled Community Embedded Study with vaccineS with low coverage rates (the Improve ACCESS Study): Study summary and anticipated significance. Canadian Pharmacists Journal, 153(2), 88-94. https://doi.org/10.1177/1715163519900221

Pharmacists as immunizers to Improve coverage and provider/recipient satisfaction: A prospective, Controlled Community Embedded Study with vaccineS with low coverage rates (the Improve ACCESS Study): Study summary and anticipated significance. / Isenor, Jennifer E.; Kervin, Melissa S.; Halperin, Donna M. et al.
In: Canadian Pharmacists Journal, Vol. 153, No. 2, 01.03.2020, p. 88-94.

Research output: Contribution to journal › Article › peer-review

Isenor, JE, Kervin, MS, Halperin, DM, Langley, J, Bettinger, JA, Top, KA, Lalji, F, Slayter, K, Kaczorowski, J, Bowles, SK, Waite, NM, Halperin, SA, Taylor, B & McNeil, S 2020, 'Pharmacists as immunizers to Improve coverage and provider/recipient satisfaction: A prospective, Controlled Community Embedded Study with vaccineS with low coverage rates (the Improve ACCESS Study): Study summary and anticipated significance', Canadian Pharmacists Journal, vol. 153, no. 2, pp. 88-94. https://doi.org/10.1177/1715163519900221

Isenor JE, Kervin MS, Halperin DM, Langley J, Bettinger JA, Top KA et al. Pharmacists as immunizers to Improve coverage and provider/recipient satisfaction: A prospective, Controlled Community Embedded Study with vaccineS with low coverage rates (the Improve ACCESS Study): Study summary and anticipated significance. Canadian Pharmacists Journal. 2020 Mar 1;153(2):88-94. doi: 10.1177/1715163519900221

Isenor, Jennifer E. ; Kervin, Melissa S. ; Halperin, Donna M. et al. / Pharmacists as immunizers to Improve coverage and provider/recipient satisfaction : A prospective, Controlled Community Embedded Study with vaccineS with low coverage rates (the Improve ACCESS Study): Study summary and anticipated significance. In: Canadian Pharmacists Journal. 2020 ; Vol. 153, No. 2. pp. 88-94.

@article{07341b42f8f643839f96a69c8e0e38ec,

title = "Pharmacists as immunizers to Improve coverage and provider/recipient satisfaction: A prospective, Controlled Community Embedded Study with vaccineS with low coverage rates (the Improve ACCESS Study): Study summary and anticipated significance",

author = "Isenor, {Jennifer E.} and Kervin, {Melissa S.} and Halperin, {Donna M.} and Joanne Langley and Bettinger, {Julie A.} and Top, {Karina A.} and Fawziah Lalji and Kathryn Slayter and Janusz Kaczorowski and Bowles, {Susan K.} and Waite, {Nancy M.} and Halperin, {Scott A.} and Beth Taylor and Shelly McNeil",

note = "Funding Information: The Improve ACCESS Team reports grant funding from GlaxoSmithKline Biologicals SA and Sanofi Pasteur Limited. Funding Information: This study was funded by the Canadian Institutes of Health Research (CIHR) through the Canadian Immunization Research Network (CIRN) and through Collaborative Research Agreements with GlaxoSmithKline Biologicals SA and Sanofi Pasteur Limited. The authors acknowledge the generous in-kind support provided by the participating community pharmacies for waiving the injection fee for the Tdap vaccine and Neighbourhood Pharmacy Association of Canada. The authors thank the dedicated pharmacists and pharmacy staff whose tremendous efforts make this study possible. Finally, we thank the following additional members of The Improve ACCESS Team: Beth Taylor and Shelly McNeil. This work was supported by the Canadian Institutes of Health Research (CIHR) through the Canadian Immunization Research Network (CIRN), GlaxoSmithKline Biologicals SA and Sanofi Pasteur Limited. All supporters were provided the opportunity to review a preliminary version of this manuscript for factual accuracy, but the authors are solely responsible for final content and interpretation. The authors received no financial support or other form of compensation related to the development of the manuscript. Funding Information: This work was supported by the Canadian Institutes of Health Research (CIHR) through the Canadian Immunization Research Network (CIRN), GlaxoSmithKline Biologicals SA and Sanofi Pasteur Limited. All supporters were provided the opportunity to review a preliminary version of this manuscript for factual accuracy, but the authors are solely responsible for final content and interpretation. The authors received no financial support or other form of compensation related to the development of the manuscript. ",

year = "2020",

month = mar,

day = "1",

doi = "10.1177/1715163519900221",

language = "English",

volume = "153",

pages = "88--94",

journal = "Canadian Pharmacists Journal",

issn = "1715-1635",

publisher = "Canadian Pharmacists Association",

number = "2",

}

TY - JOUR

T1 - Pharmacists as immunizers to Improve coverage and provider/recipient satisfaction

T2 - A prospective, Controlled Community Embedded Study with vaccineS with low coverage rates (the Improve ACCESS Study): Study summary and anticipated significance

AU - Isenor, Jennifer E.

AU - Kervin, Melissa S.

AU - Halperin, Donna M.

AU - Langley, Joanne

AU - Bettinger, Julie A.

AU - Top, Karina A.

AU - Lalji, Fawziah

AU - Slayter, Kathryn

AU - Kaczorowski, Janusz

AU - Bowles, Susan K.

AU - Waite, Nancy M.

AU - Halperin, Scott A.

AU - Taylor, Beth

AU - McNeil, Shelly

N1 - Funding Information: The Improve ACCESS Team reports grant funding from GlaxoSmithKline Biologicals SA and Sanofi Pasteur Limited. Funding Information: This study was funded by the Canadian Institutes of Health Research (CIHR) through the Canadian Immunization Research Network (CIRN) and through Collaborative Research Agreements with GlaxoSmithKline Biologicals SA and Sanofi Pasteur Limited. The authors acknowledge the generous in-kind support provided by the participating community pharmacies for waiving the injection fee for the Tdap vaccine and Neighbourhood Pharmacy Association of Canada. The authors thank the dedicated pharmacists and pharmacy staff whose tremendous efforts make this study possible. Finally, we thank the following additional members of The Improve ACCESS Team: Beth Taylor and Shelly McNeil. This work was supported by the Canadian Institutes of Health Research (CIHR) through the Canadian Immunization Research Network (CIRN), GlaxoSmithKline Biologicals SA and Sanofi Pasteur Limited. All supporters were provided the opportunity to review a preliminary version of this manuscript for factual accuracy, but the authors are solely responsible for final content and interpretation. The authors received no financial support or other form of compensation related to the development of the manuscript. Funding Information: This work was supported by the Canadian Institutes of Health Research (CIHR) through the Canadian Immunization Research Network (CIRN), GlaxoSmithKline Biologicals SA and Sanofi Pasteur Limited. All supporters were provided the opportunity to review a preliminary version of this manuscript for factual accuracy, but the authors are solely responsible for final content and interpretation. The authors received no financial support or other form of compensation related to the development of the manuscript.

PY - 2020/3/1

Y1 - 2020/3/1

UR - http://www.scopus.com/inward/record.url?scp=85081629818&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85081629818&partnerID=8YFLogxK

U2 - 10.1177/1715163519900221

DO - 10.1177/1715163519900221

M3 - Article

AN - SCOPUS:85081629818

SN - 1715-1635

VL - 153

SP - 88

EP - 94

JO - Canadian Pharmacists Journal

JF - Canadian Pharmacists Journal

IS - 2

ER -

Pharmacists as immunizers to Improve coverage and provider/recipient satisfaction: A prospective, Controlled Community Embedded Study with vaccineS with low coverage rates (the Improve ACCESS Study): Study summary and anticipated significance

Bibliographical note

ASJC Scopus Subject Areas

UN SDGs

Access to Document

Other files and links

Cite this